US Patent Issued to The Board of Regents of The University of Texas System on Nov. 25 for "Treatment of Fuchs' endothelial corneal dystrophy" (Texas Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,118, issued on Nov. 25, was assigned to The Board of Regents of The University of Texas System (Austin, Texas).

"Treatment of Fuchs' endothelial corneal dystrophy" was invented by Venkateswara V. Mootha (Coppell, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are compounds and methods useful in the treatment of Fuchs' Endothelial Corneal Dystrophy (FECD)."

The patent was filed on Nov. 8, 2022, under Application No. 18/053,559.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d...